Company profile
Sava | A New Paradigm In Biosensing
SAVA is reinventing health monitoring with a novel biosensing platform enabling real-time, affordable, and painless molecular monitoring.
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last accounts made up date
Last confirmation statement made up date
Company registered at Companies House
1 Jul 2021 to 30 Jun 2023
Caura intends to develop a revolutionary child-friendly TRL8 real-time continuous glucose monitoring device (CGM) that addresses the main issues associated with current conventional CGM systems. The cost of diabetes to healthcare systems has grown to £558bn globally (£9.8bn NHS) , with the majority of costs associated with the short-and long-term complica...
1 Jul 2020 to 31 Oct 2021
The human body is unique, with each person having varying metabolic needs, energy expenditure and a diverse response to exercise and food. Quantifying how diet, hydration and exercise impact our bodies in such singular ways is currently impossible outside of the lab, with people currently reliant on wearables that provide generic data such as heart-rate, ...
